Status:
COMPLETED
Implementation of a Pharmacist-Based, Post-Chemotherapy Follow-up Clinic
Lead Sponsor:
Cedars-Sinai Medical Center
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to determine the impact of pharmacists on reducing chemotherapy-related side effects by providing education before and after patients receive intravenous chemotherapy at o...
Detailed Description
The study involves participation at a single timepoint only. Participants who consented to participate and are considered eligible will be interviewed by a pharmacist via phone at approximately 7 bus...
Eligibility Criteria
Inclusion
- At least 18 years old
- Diagnosed with cancer and is receiving treatment with intravenous chemotherapy
- Treatment initiated at Cedars-Sinai Cancer Samuel Oschin Cancer Center (SOCC) or Cedars-Sinai Cancer Beverly Hills (CSCBH)
- English-speaking or lives with English-speaking person
- Access to a working phone
Exclusion
- Received follow-up calls through other specialty pharmacy program
- History of infusion related reactions
- Declined participation on follow-up interview
- Age less than 18 years old
- Non-English speaking
- Electronic health record flagged for research opt out
Key Trial Info
Start Date :
July 20 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 30 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05965206
Start Date
July 20 2024
End Date
April 30 2025
Last Update
May 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cedars-Sinai Medical Center
Los Angeles, California, United States, 90048